JPWO2020204173A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020204173A5 JPWO2020204173A5 JP2021512328A JP2021512328A JPWO2020204173A5 JP WO2020204173 A5 JPWO2020204173 A5 JP WO2020204173A5 JP 2021512328 A JP2021512328 A JP 2021512328A JP 2021512328 A JP2021512328 A JP 2021512328A JP WO2020204173 A5 JPWO2020204173 A5 JP WO2020204173A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- alkyl
- acceptable salt
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019072911 | 2019-04-05 | ||
| JP2019072911 | 2019-04-05 | ||
| PCT/JP2020/015364 WO2020204173A1 (ja) | 2019-04-05 | 2020-04-03 | 水溶性アジュバントおよびそれを含有する組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020204173A1 JPWO2020204173A1 (https=) | 2020-10-08 |
| JPWO2020204173A5 true JPWO2020204173A5 (https=) | 2023-04-12 |
| JP7573516B2 JP7573516B2 (ja) | 2024-10-25 |
Family
ID=72668989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512328A Active JP7573516B2 (ja) | 2019-04-05 | 2020-04-03 | 水溶性アジュバントおよびそれを含有する組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220241409A1 (https=) |
| EP (1) | EP3954382A4 (https=) |
| JP (1) | JP7573516B2 (https=) |
| KR (1) | KR20220004030A (https=) |
| CN (1) | CN113905758A (https=) |
| AU (1) | AU2020255935A1 (https=) |
| CA (1) | CA3136066A1 (https=) |
| MX (1) | MX2021012200A (https=) |
| WO (1) | WO2020204173A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6718562B1 (ja) | 2018-07-24 | 2020-07-08 | 日本化薬株式会社 | エポキシ樹脂、エポキシ樹脂組成物、炭素繊維強化複合材料用エポキシ樹脂組成物、プリプレグ、炭素繊維強化複合材料 |
| AU2022327884A1 (en) * | 2021-08-12 | 2024-02-22 | International Institute Of Cancer Immunology, Inc. | Pharmaceutical composition and method for treatment or prevention of cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006078059A1 (ja) * | 2005-01-19 | 2006-07-27 | Dainippon Sumitomo Pharma Co., Ltd. | 希釈用乳化組成物および癌ワクチン組成物 |
| ES2352855T3 (es) | 2005-11-30 | 2011-02-23 | International Institute Of Cancer Immunology, Inc. | Nuevos compuestos peptídicos del tumor de wilms. |
| KR20110117705A (ko) * | 2009-02-11 | 2011-10-27 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 톨-유사 수용체 조정제 및 질병의 치료 |
| MY171854A (en) * | 2013-03-29 | 2019-11-05 | Sumitomo Dainippon Pharma Co Ltd | Wt1 antigen peptide conjugate vaccine |
| EP2980097A4 (en) * | 2013-03-29 | 2017-03-08 | Sumitomo Dainippon Pharma Co., Ltd. | Conjugate vaccine using trimming function of erap1 |
| ES2805724T3 (es) * | 2015-09-29 | 2021-02-15 | Sumitomo Dainippon Pharma Co Ltd | Compuestos de adenina conjugados y su uso como adyuvantes de vacunas |
| CN110582300B (zh) * | 2017-05-02 | 2024-08-02 | 尼克塔治疗公司 | 肿瘤免疫治疗性治疗方法 |
| CN111093623A (zh) * | 2017-07-10 | 2020-05-01 | 免疫疫苗技术公司 | 药物组合物、使用限定大小的脂质囊泡颗粒的制备方法及其用途 |
| US10494370B2 (en) * | 2017-08-16 | 2019-12-03 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor |
| CN112188902A (zh) * | 2018-05-29 | 2021-01-05 | 百时美施贵宝公司 | 用于前药和缀合物的经修饰的自消灭部分以及使用和制造方法 |
-
2020
- 2020-04-03 EP EP20784004.2A patent/EP3954382A4/en active Pending
- 2020-04-03 US US17/600,903 patent/US20220241409A1/en active Pending
- 2020-04-03 AU AU2020255935A patent/AU2020255935A1/en not_active Abandoned
- 2020-04-03 CA CA3136066A patent/CA3136066A1/en active Pending
- 2020-04-03 WO PCT/JP2020/015364 patent/WO2020204173A1/ja not_active Ceased
- 2020-04-03 JP JP2021512328A patent/JP7573516B2/ja active Active
- 2020-04-03 MX MX2021012200A patent/MX2021012200A/es unknown
- 2020-04-03 KR KR1020217033642A patent/KR20220004030A/ko active Pending
- 2020-04-03 CN CN202080041585.5A patent/CN113905758A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6849197B2 (ja) | リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用 | |
| JP6133491B2 (ja) | ジヒドロピリドピリミジン化合物 | |
| CN103497177B (zh) | 作为c‑Met抑制剂的氨基芳香杂环类化合物及其制备方法 | |
| JP2013527142A5 (https=) | ||
| AU2009292555B2 (en) | Novel prostaglandin I2 derivative | |
| WO2012102297A1 (ja) | ピラゾロピリジン誘導体、またはその薬理学的に許容される塩 | |
| FR2873694A1 (fr) | Nouveaux aza-indoles inhibiteurs de la mtp et apob | |
| JP2006508970A5 (https=) | ||
| JP2016526023A (ja) | Ｓｔａｔ６阻害剤 | |
| WO2006069525A1 (en) | Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof | |
| JPWO2020204173A5 (https=) | ||
| TW202233579A (zh) | 化合物、醛去氫酶2活化劑、醫藥組合物、以及治療及/或預防藥 | |
| US20030220402A1 (en) | Cancer remedy comprising anthranilic acid derivatives as active ingredients | |
| KR20120075481A (ko) | 치료적 유용성을 갖는 수용체 조절제로서 쿠마린 화합물 | |
| JPWO2020204172A5 (https=) | ||
| ES2955723T3 (es) | Nuevas piridazinas | |
| JP5574435B2 (ja) | アルキル化カテキンの効率的製造方法 | |
| JP2004509077A (ja) | カルシライティック化合物 | |
| US20260078111A1 (en) | Carbonic anhydrase enzyme inhibitors and methods of use thereof | |
| CZ20031144A3 (cs) | Kalcilytické sloučeniny | |
| EP1383511B1 (en) | Calcilytic compounds | |
| JP5302214B2 (ja) | Ｔｒｐｖ１受容体拮抗薬としてのｏ−置換ジベンジル尿素誘導体 | |
| CN114671856B (zh) | 多取代的尿嘧啶衍生物及其用途 | |
| IL276783B1 (en) | The composition and pharmaceutical compound containing it | |
| TW200403228A (en) | New anthracene derivatives and their use as pharmaceutical preparations |